Article

Improving Response in Antidepressant Therapy: Focus on Deplin®

Author(s):

Alfasigma USA, Inc.

Related Videos
lithium
social media
ketamine
media
AI
older person
suicide prevention
McIntyre
John Krystal
Psychiatrists for Mental Health for All
Related Content
schizophrenia
May 22nd 2025

Major Changes in the Treatment of Schizophrenia: A Long Time in the Making

Peter J. Weiden, MD
Lifestyle Interventions for ADHD
May 4th 2022

Lifestyle Interventions for ADHD

Study Finds Zuranolone Effective for Anhedonia in Patients With PPD
May 20th 2025

Study Finds Zuranolone Effective for Anhedonia in Patients With PPD

Heidi Anne Duerr, MPH
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
Novel PDE10A Inhibitor for Acute Schizophrenia Exacerbation Presented at APA Annual Meeting
May 18th 2025

Novel PDE10A Inhibitor for Acute Schizophrenia Exacerbation Presented at APA Annual Meeting

Heidi Anne Duerr, MPH
borderline personality disorder
May 18th 2025

Borderline Personality Disorder and Online Behaviors: New Information Presented at APA Annual Meeting

Leah Kuntz
© 2025 MJH Life Sciences

All rights reserved.